Our findings are consistent with a report by Igney et al. in which mice with a deficiency in neutrophil cytotoxicity were injected with FasL-expressing tumours, and the tumour growth rate was the same as in wild-type mice [18]. This evidence concerns the gene FASLG and neoplasm.